KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Other financing activities (2016 - 2025)

Gilead Sciences (GILD) has disclosed Other financing activities for 17 consecutive years, with -$63.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other financing activities fell 34.04% year-over-year to -$63.0 million, compared with a TTM value of -$440.0 million through Dec 2025, down 56.58%, and an annual FY2025 reading of -$440.0 million, down 56.58% over the prior year.
  • Other financing activities was -$63.0 million for Q4 2025 at Gilead Sciences, up from -$137.0 million in the prior quarter.
  • Across five years, Other financing activities topped out at -$6.0 million in Q2 2021 and bottomed at -$176.0 million in Q1 2025.
  • Average Other financing activities over 5 years is -$65.9 million, with a median of -$55.0 million recorded in 2024.
  • Peak annual rise in Other financing activities hit 21.43% in 2021, while the deepest fall reached 700.0% in 2021.
  • Year by year, Other financing activities stood at -$11.0 million in 2021, then crashed by 109.09% to -$23.0 million in 2022, then tumbled by 47.83% to -$34.0 million in 2023, then plummeted by 38.24% to -$47.0 million in 2024, then crashed by 34.04% to -$63.0 million in 2025.
  • Business Quant data shows Other financing activities for GILD at -$63.0 million in Q4 2025, -$137.0 million in Q3 2025, and -$64.0 million in Q2 2025.